Lavipharm S.A. Profit Margin

Lavipharm S.A. (LAVI.AT) currently reports a profit margin of 7.75% as of June 2026. That compares with 8.38% in the prior-year period — down 7.5% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore Lavipharm S.A.'s profit margin history and peer comparisons.

Lavipharm S.A.'s profit margin decreased from 8.38% to 7.75% — a 7.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lavipharm S.A.'s profit margin of 7.75% is lower than the its sector sector average of 13.16%. That is roughly 41.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Lavipharm S.A.'s current 7.75% should be judged against industry norms (sector average: 13.16%) and against LAVI.AT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 7.75%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Lavipharm S.A., and consider following LAVI.AT for alerts when major investors trade the stock.